Literature DB >> 2148723

Characteristics of T-lymphocytes infiltrating human B-cell lymphomas.

P Marquardt1, H K Müller-Hermelink.   

Abstract

Using a recently described technique for direct expansion of human T-lymphocytes isolated from small intestine biopsies, we have investigated the local cellular immune response in six patients with B-cell lymphomas of various subtypes. T-cell lines (TCL) were established by seeding tumor-infiltrating T-lymphocytes (T1TL) at limiting dilution in the presence of irradiated feeder cells in culture medium containing rIl-2 and phytohemagglutinin (PHA). About 1/50 T-cells gave rise to a TCL; they all were CD3+. The CD4/CD8 ratio was 3.8:1 before and after cloning. Of 45 TCLs analysed so far from one patient with B-cell lymphoma of the lung, 4 were cytotoxic as shown by their ability to exert lectin-dependent cytotoxicity against allogeneic target cells. Of these, 3 demonstrated specificity for the autologous malignant B-cells. Five TCLs lysed the NK-sensitive K562 cell line in a HLA-unrestricted manner. When tested for antigen-specific proliferative activity, 4 TCLS only responded to the autologous lymphoma cells, but 5 TCLs reacted to the autoantigenic ganglioside GM1. Southern Blot analyses did not show a clonal pattern of T-cell receptor gene rearrangement within all TITL populations. The peripheral T-lymphocytes of the lymphoma patients showed a drastically reduced response to the mitogens PHA. Concanavalin A, and pokeweed mitogen. The present report demonstrates that it is possible to analyze TITL at clonal level. This technique may be the only means of investigating the specificity of the TITL and may help us to identify the relevant tumor-associated autoantigens if tumor-induced autoimmunization is indeed one of the mechanisms that control the growth of tumors and metastases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148723      PMCID: PMC1568006          DOI: 10.1289/ehp.9088233

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours.

Authors:  B M Vose; M Moore
Journal:  Int J Cancer       Date:  1979-11-15       Impact factor: 7.396

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  De-novo brain tumours in renal-transplant recipients.

Authors:  S A Schneck; I Penn
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

4.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

5.  Abnormal phytohemagglutinin-induced T-cell proliferative responses in Hodgkin's disease.

Authors:  R S Schulof; M J Lacher; S Gupta
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

Review 6.  Depressed immunity and the development of cancer.

Authors:  I Penn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

7.  Use of whole blood methods in assessment of immune parameters in immunodeficiency states.

Authors:  M A Fletcher; G C Baron; M R Ashman; M A Fischl; N G Klimas
Journal:  Diagn Clin Immunol       Date:  1987

8.  Escape mechanisms of melanoma from immune system by soluble melanoma antigen.

Authors:  K Takahashi; K Ono; Y Hirabayashi; M Taniguchi
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

9.  Phenotypic markers and functional characteristics of T lymphocyte clones from cerebrospinal fluid in multiple sclerosis.

Authors:  B Fleischer; P Marquardt; S Poser; H W Kreth
Journal:  J Neuroimmunol       Date:  1984-12       Impact factor: 3.478

10.  Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis.

Authors:  R Martin; P Marquardt; S O'Shea; M Borkenstein; H W Kreth
Journal:  J Neuroimmunol       Date:  1989-06       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.